News | Published:

Drugs in the headlines

Nature Medicine volume 15, page 1353 (2009) | Download Citation

Subjects

  • An Erratum to this article was published on 01 January 2010
  • An Erratum to this article was published on 01 January 2010

This article has been updated

This year witnessed both surprising successes and unexpected failures in basic and clinical drug development. There were also mixed results for some newly tested drugs, which will probably prompt a careful reassessment of their therapeutic value. Our drug watch compilation summarizes the most talked about therapies of the year.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Change history

  • 08 December 2009

    In the version of this article initially published, the sentence “However, it failed in trials against early-stage colon cancers, and reports suggested that it might promote cancer metastasis in certain circumstances” was incorrect. Although it has been suggested that other strategies targeting blood vessel growth factors might promote tumor growth, this has not been specifically shown for Avastin. The text should read “However, it failed in trials against early-stage colon cancers. Reports have also suggested that targeting blood vessel growth factors might promote cancer metastasis in certain circumstances.” The error has been corrected in the HTML and PDF versions of the article.

  • 11 December 2009

    In the version of this article initially published, it was stated that Denosumab had gained approval for use in osteoporosis treatment, when in fact it had only been recommended for approval. Additionally, the approval of its preventive use was recommended against until further data are available. The text should read “Several clinical trials tested this antibody, which counteracts bone loss. Although a US Food and Drug Administration committee recommended its approval for osteoporosis treatment, it recommended against approval of its preventive use—and its use to treat bone loss in certain cancer cases—until more data are available.” The error has been corrected in the HTML and PDF versions of the article.

Author information

Affiliations

  1. New York

    • Victoria Aranda

Authors

  1. Search for Victoria Aranda in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nm1209-1353a

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing